Alejandro Martín, Eulogio Conde, Montserrat Arnan, Miguel A. Canales, Guillermo Deben, Juan M. Sancho, Rafael Andreu, Antonio Salar, Pedro García-Sanchez, Lourdes Vázquez, Sara Nistal, María-José Requena, Eva M. Donato, José A. González, Ángel León, Concepción Ruiz, Carlos Grande, Eva González-Barca, María-Dolores Caballero. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. haematol [Internet]. 2008Dec.2 [cited 2024Apr.18];93(12):1829-36. Available from: https://haematologica.org/article/view/5106